Wellington Management Group
CRMD icon

Wellington Management Group’s CorMedix CRMD Stock Holding History

Wellington Management Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
215,795
+11,530
+6% +$91.1K ﹤0.01% 1664
2026
Q1 		$1.39M Sell
204,265
-17,495
-8% -$129K ﹤0.01% 1614
2025
Q4 		$2.58M Sell
221,760
-28,608
-11% -$316K ﹤0.01% 1534
2025
Q3 		$2.91M Buy
250,368
+79,250
+46% +$958K ﹤0.01% 1558
2025
Q2 		$2.11M Buy
171,118
+7,169
+4% +$79.1K ﹤0.01% 1574
2025
Q1 		$1.01M Sell
163,949
-14,837
-8% -$154K ﹤0.01% 1708
2024
Q4 		$1.45M Sell
178,786
-2,162
-1% -$21.6K ﹤0.01% 1649
2024
Q3 		$1.46M Buy
180,948
+102,527
+131% +$555K ﹤0.01% 1633
2024
Q2 		$340K Buy
+78,421
New +$398K ﹤0.01% 1819

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wellington Management Group's CRMD Position: Q2 2026 in Review

Wellington Management Group increased its CorMedix (CRMD) stake by 5.6% in Q2 2026, buying an estimated $91.1K and bringing the position to 215,795 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Wellington Management Group first reported a position in CRMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.91M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Wellington Management Group held 215,795 shares of CorMedix worth $1.69M as of Q2 2026.
  • Wellington Management Group bought 11,530 CorMedix shares in Q2 2026, an estimated $91.1K.
  • CorMedix made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1664 holding.
  • Wellington Management Group first reported a position in CorMedix in Q2 2024 and has held it in 9 quarters since.
  • Wellington Management Group's CorMedix position peaked at $2.91M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.